Hjem › Alopecia areata › Florida
Alopecia areata kliniske forsøg i Florida
8 studier for Alopecia areata søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Pediatric Skin Research - Miami /ID# 283281, Miami
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 2. okt. 2026 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Health Clinical Research, LLC, Cutler Bay
RekruttererFase 2
Alder 18 til 50 · Alle køn · Opdateret 22. sep. 2026 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Pediatric Skin Research, Miami
- Skin Research of South Florida, Miami
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT06873945HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
- James A. Haley Veterans' Hospital, Tampa
RekruttererFase 1
Alder 18 til 70 · Alle køn · Opdateret 15. sep. 2026 · NCT07049328A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Skin Research of South Florida, Miami
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Skin Care Research Boca Raton /ID# 258012, Boca Raton
- Skin Care Research - Hollywood /ID# 259210, Hollywood
- GSI Clinical Research, LLC /ID# 259352, Margate
- og 2 flere
RekruttererFase 3
Alder 12 til 63 · Alle køn · Opdateret 3. aug. 2026 · NCT06012240A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Pediatric Skin Research, Miami
- D&H Tamarac Research Center, Tamarac
RekruttererFase 3
Alder 6 til 14 · Alle køn · Opdateret 28. apr. 2026 · NCT07029828Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- D&H Doral Research Center, Doral
- Skin Care Research, Llc - Hollywood, Hollywood
- Ilumina Medical Research Llc, Kissimmee
- og 12 flere
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 28. jan. 2026 · NCT07133308Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.